Sign inGet started

Glessner Coleen

Insider CIK 1919170 · EBS EVP, Quality & Ethics, and CPL

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
EBS Emergent BioSolutions Inc. F Tax w/h2026-06-082026-06-102,018$8.00 $16.1K202,201SEC↗
EBS Emergent BioSolutions Inc. A Award2026-04-292026-05-01100,111— $0204,219SEC↗
EBS Emergent BioSolutions Inc. F Tax w/h2026-03-052026-03-058,199$8.44 $69.2K104,108SEC↗
EBS Emergent BioSolutions Inc. A Award deriv2026-03-032026-03-0544,834— $0294,447SEC↗
EBS Emergent BioSolutions Inc. F Tax w/h2026-03-012026-03-03313$8.15 $2.6K112,307SEC↗
EBS Emergent BioSolutions Inc. F Tax w/h2026-02-062026-02-102,852$10.92 $31.1K112,620SEC↗
EBS Emergent BioSolutions Inc. D To issuer2026-02-062026-02-1028,847$10.92 $315.0K115,472SEC↗
EBS Emergent BioSolutions Inc. S Sale2025-10-072025-10-1630,608$10.00 $306.1K144,319SEC↗
EBS Emergent BioSolutions Inc. F Tax w/h2025-06-082025-06-101,249$6.63 $8.3K174,927SEC↗
EBS Emergent BioSolutions Inc. F Tax w/h2025-04-072025-04-09480$4.44 $2.1K176,176SEC↗
EBS Emergent BioSolutions Inc. A Award deriv2025-03-062025-03-1062,500— $0249,613SEC↗
EBS Emergent BioSolutions Inc. A Award2025-03-062025-03-1062,500— $0176,656SEC↗
EBS Emergent BioSolutions Inc. F Tax w/h2025-03-012025-03-04313$7.48 $2.3K114,156SEC↗
EBS Emergent BioSolutions Inc. D To issuer2025-02-122025-03-045,913— $0138,547SEC↗
EBS Emergent BioSolutions Inc. D To issuer2025-02-122025-03-0424,078— $0114,469SEC↗
EBS Emergent BioSolutions Inc. F Tax w/h2024-12-082024-12-1018,674$9.01 $168.3K144,460SEC↗
EBS Emergent BioSolutions Inc. F Tax w/h2024-06-082024-06-111,249$6.19 $7.7K163,134SEC↗
EBS Emergent BioSolutions Inc. F Tax w/h2024-04-072024-04-09585$2.29 $1.3K164,383SEC↗
EBS Emergent BioSolutions Inc. A Award deriv2024-03-132024-03-15125,000— $0187,113SEC↗
EBS Emergent BioSolutions Inc. F Tax w/h2024-03-012024-03-04381$3.39 $1.3K164,968SEC↗
EBS Emergent BioSolutions Inc. A Award deriv2023-06-092023-06-1330,770— $062,113SEC↗
EBS Emergent BioSolutions Inc. A Award2023-06-092023-06-1315,385— $0134,579SEC↗
EBS Emergent BioSolutions Inc. A Award2023-06-092023-06-1330,770— $0165,349SEC↗
EBS Emergent BioSolutions Inc. F Tax w/h2023-04-072023-04-10480— $0120,154SEC↗
EBS Emergent BioSolutions Inc. A Award deriv2023-03-022023-03-067,692— $031,343SEC↗
EBS Emergent BioSolutions Inc. A Award2023-03-022023-03-067,692— $0119,674SEC↗
EBS Emergent BioSolutions Inc. A Award2023-03-022023-03-063,846— $0111,982SEC↗
EBS Emergent BioSolutions Inc. A Award2022-12-092022-12-1324,078— $035,904SEC↗
EBS Emergent BioSolutions Inc. A Award2022-12-092022-12-1372,232— $0108,136SEC↗
EBS Emergent BioSolutions Inc. A Award deriv2022-04-082022-04-1223,651$42.28 $1000.0K23,651SEC↗
EBS Emergent BioSolutions Inc. A Award2022-04-082022-04-125,913— $011,826SEC↗
EBS Emergent BioSolutions Inc. A Award2022-04-082022-04-125,913— $05,913SEC↗